Symphony Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-4,399
| Closed | -$717K | – | 284 |
|
|
2018
Q2 | $717K | Sell |
4,399
-95
| -2% | -$15.5K | 0.14% | 136 |
|
|
2018
Q1 | $732K | Sell |
4,494
-322
| -7% | -$52.4K | 0.09% | 194 |
|
|
2017
Q4 | $722K | Sell |
4,816
-73
| -1% | -$10.9K | 0.07% | 216 |
|
|
2017
Q3 | $743K | Sell |
4,889
-36
| -0.7% | -$5.47K | 0.08% | 216 |
|
|
2017
Q2 | $634K | Sell |
4,925
-239
| -5% | -$30.8K | 0.07% | 240 |
|
|
2017
Q1 | $565K | Sell |
5,164
-1,112
| -18% | -$122K | 0.05% | 265 |
|
|
2016
Q4 | $463K | Sell |
6,276
-217
| -3% | -$16K | 0.05% | 293 |
|
|
2016
Q3 | $566K | Sell |
6,493
-6,295
| -49% | -$549K | 0.06% | 249 |
|
|
2016
Q2 | $1.1M | Sell |
12,788
-5,773
| -31% | -$497K | 0.12% | 171 |
|
|
2016
Q1 | $1.48M | Buy |
18,561
+10,475
| +130% | +$833K | 0.16% | 145 |
|
|
2015
Q4 | $1.02M | Sell |
8,086
-279
| -3% | -$35.1K | 0.11% | 190 |
|
|
2015
Q3 | $871K | Sell |
8,365
-209
| -2% | -$21.8K | 0.11% | 209 |
|
|
2015
Q2 | $1.06M | Sell |
8,574
-1,122
| -12% | -$138K | 0.13% | 173 |
|
|
2015
Q1 | $1.14M | Buy |
9,696
+855
| +10% | +$101K | 0.13% | 164 |
|
|
2014
Q4 | $1.05M | Sell |
8,841
-3,813
| -30% | -$453K | 0.13% | 160 |
|
|
2014
Q3 | $1.42M | Buy |
12,654
+3,194
| +34% | +$359K | 0.15% | 134 |
|
|
2014
Q2 | $895K | Sell |
9,460
-464
| -5% | -$43.9K | 0.09% | 234 |
|
|
2014
Q1 | $702K | Buy |
+9,924
| New | +$702K | 0.07% | 250 |
|